Ligand profile
SA2
Ligand co-crystallized with this exact protein (Protein Data Bank).
Bound to: KP13_32248 — Beta-lactamase SHV-12
Identifiers
Database identifiers and provenance.
- Ligand ID
SA2- PDB
2h5s- UniProt (this protein)
P0AD64- Target protein
- KP13_32248
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 167.3
- −1 ≤ LogP ≤ 5 -0.48
- MW ≤ 500 Da 365.4
- LogP ≤ 5 -0.48
- H-bond donors ≤ 5 4
- H-bond acceptors ≤ 10 7
- Rotatable bonds ≤ 10 12
- TPSA ≤ 140 Ų 167.3
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
C[C@](COC(=O)CCCC(=O)O)([C@H](C(=O)O)N\C=C\C=O)[S@](=O)OC[C@](COC(=O)CCCC(=O)O)([C@H](C(=O)O)N\C=C\C=O)[S@](=O)O
InChI=1S/C13H19NO9S/c1-13(24(21)22,11(12(19)20)14-6-3-7-15)8-23-10(18)5-2-4-9(16)17/h3,6-7,11,14H,2,4-5,8H2,1H3,(H,16,17)(H,19,20)(H,21,22)/b6-3+/t11-,13-/m0/s1InChI=1S/C13H19NO9S/c1-13(24(21)22,11(12(19)20)14-6-3-7-15)8-23-10(18)5-2-4-9(16)17/h3,6-7,11,14H,2,4-5,8H2,1H3,(H,16,17)(H,19,20)(H,21,22)/b6-3+/t11-,13-/m0/s1
ZLJAMSCQNNEARN-QDZHIHTESA-NZLJAMSCQNNEARN-QDZHIHTESA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ sequence
- Source
- PDB
- Binding sites
- PF00144' 'PF13354
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand SA2 →
- PDB RCSB structure 2h5s →
- UniProt UniProt P0AD64 (same protein) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “SA2”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_32248.
PDB 43
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 100
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).